Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cimzia vs Cimzia Plus Azathioprine in Active, Moderate to Severe Crohn's Disease
NCT01817972Phase 3Unknown
- Sponsor
- Gastroenterology Research of America
- Start
- Mar 2013
- Primary completion
- Jun 2014
- Modality
- Antibody Fragments, Polymer-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 3 trial of certolizumab pegol in Crohn's disease, sponsored by Gastroenterology Research of America. Status: unknown.
02
Drugs
certolizumab pegol
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT01817972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01817972.